AACG vs NSRX
Comparison between ATA Creativity Global (AACG, Company) and Nasus Pharma Ltd (NSRX, Company).
AACG is from the Consumer Defensive sector, while NSRX is from the Healthcare sector.
AACG vs NSRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
AACG vs NSRX - Historical Returns
Returns include dividend reinvestment.
AACG vs NSRX - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | AACG | NSRX |
|---|---|---|
| 2026 | +12.49% | -57.48% |
| 2025 | -10.19% | +10.91% |
| 2024 | -13.15% | N/A |
| 2023 | -7.96% | N/A |
| 2022 | +7.00% | N/A |
| 2021 | -9.28% | N/A |
| 2020 | -11.85% | N/A |
| 2019 | +44.68% | N/A |
| 2018 | -32.65% | N/A |
| 2017 | +28.75% | N/A |
| 2016 | -41.68% | N/A |
| 2015 | +36.67% | N/A |
| 2014 | +20.37% | N/A |
| 2013 | -33.17% | N/A |
| 2012 | -2.61% | N/A |
| 2011 | +111.75% | N/A |
| 2010 | -22.37% | N/A |
| 2009 | -14.86% | N/A |
| 2008 | -41.83% | N/A |
AACG vs NSRX Drawdown Comparison
The maximum drawdown for AACG was -96.49%, occurring on Sep 16, 2024. This drawdown has not yet recovered.
The maximum drawdown for NSRX was -78.03%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current AACG drawdown is -93.71%. The current NSRX drawdown is -64.92%.
| Rank | AACG | NSRX |
|---|---|---|
| #1 | -96.49% Feb 4, 2021 - Sep 16, 2024 | -78.03% Dec 31, 2025 - Mar 30, 2026 |
| #2 | -84.57% May 23, 2008 - Apr 10, 2019 | -30.96% Aug 19, 2025 - Dec 31, 2025 |
| #3 | -82.60% Apr 10, 2019 - Feb 4, 2021 | -2.42% Aug 13, 2025 - Aug 18, 2025 |
| #4 | -31.95% Mar 11, 2008 - May 19, 2008 | N/A |
| #5 | -5.76% Jan 31, 2008 - Feb 20, 2008 | N/A |
| #6 | -4.24% Feb 21, 2008 - Feb 29, 2008 | N/A |
| #7 | -2.86% Jan 29, 2008 - Jan 31, 2008 | N/A |
| #8 | -1.54% Mar 3, 2008 - Mar 7, 2008 | N/A |
| #9 | -0.55% May 21, 2008 - May 23, 2008 | N/A |
Correlation
Correlation between AACG and NSRX is 0.38 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks